By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

The New England Journal of Medicine 

10 Shattuck Street

Boston  Massachusetts  02115-6094  U.S.A.
Phone: 617-734-9800 Fax: 617-739-9864


SEARCH JOBS


Industry
Services

Segment
Publisher





Company News
Geron Corporation (GERN) Release: Dual Publications In The New England Journal of Medicine Highlight Transformative Potential Of Imetelstat In Hematologic Myeloid Malignancies 9/3/2015 7:20:29 AM
The Medicines Company (MDCO) Release: MATRIX Trial Results Presented At Hot Line Session Of ESC Congress 2015 And Simultaneously Published In The New England Journal of Medicine 9/2/2015 11:07:09 AM
St. Jude Medical (STJ) Release: LEADLESS II Trial Results Published In The New England Journal of Medicine Confirm The Positive Benefits Of The Nanostim Leadless Pacemaker 8/31/2015 11:15:07 AM
Gilead (GILD) Release: Results From The AMBITION Study Of First-Line Treatment With Letairis And Tadalafil In Pulmonary Arterial Hypertension Published In The New England Journal of Medicine 8/27/2015 10:43:15 AM
Genmab A/S (GEN.CO) Release: Data Published In The New England Journal of Medicine Shows Daratumumab Monotherapy Induced Durable Responses In Heavily Pre-Treated Relapsed Or Refractory Multiple Myeloma Patients 8/27/2015 7:16:19 AM
Janssen Research & Development Release: Data Published In The New England Journal of Medicine Show Single-Agent Daratumumab Demonstrated A 36 Percent Overall Response Rate And Tolerable Safety Profile In Heavily Pre-Treated Multiple Myeloma Patients 8/27/2015 6:15:01 AM
Isis Pharma (ISIS) Release: Positive Clinical Data From Volanesorsen Published In The New England Journal of Medicine 7/30/2015 11:36:38 AM
Sarepta (SRPT) Announces The New England Journal of Medicine Publication Of Phase I Clinical Data Of Marburg Drug Candidate, AVI-7288, Supporting Safety Of The Pmoplus Platform 7/23/2015 10:56:28 AM
Efficacy Results Of Otsuka Pharma’s Delamanid (Deltyba) For Extensively Drug-Resistant Tuberculosis (XDR-TB) Published In The New England Journal of Medicine 7/16/2015 11:12:48 AM
C. R. Bard, Inc. (BCR) Release: The New England Journal of Medicine Publishes LEVANT 2 Results For The Lutonix Drug Coated Balloon, Showing Superior Efficacy Compared To Standard PTA 6/25/2015 12:32:50 PM
12345678910...
//-->